Selank Research

Selank is a synthetic heptapeptide analog of tuftsin (Thr-Lys-Pro-Arg), developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. It is studied for its activity in stress-response, anxiety-related signaling, and immune modulation pathways, and is registered as a pharmaceutical in Russia.

Research Areas

Anxiolytic & Stress Signaling Research

Studies investigate Selank's effects on anxiety-related neural signaling pathways, including its interactions with GABA-A receptor modulation research and stress-hormone signaling in both animal models and human subjects.

↗ Semenova et al. 2010 — Selank in anxiety pathway research

BDNF & Neurotrophic Signaling

Research has reported Selank's influence on BDNF expression and the balance between BDNF and other neurotrophic factors involved in mood-regulation and cognitive pathway research.

↗ Zozulya et al. 2001 — Selank and BDNF signaling

Immune-Neurological Signaling Crossover

As a tuftsin analog, Selank is studied for interactions between immune signaling (cytokine modulation) and central nervous system pathway research, examining psychoneuroimmunology connections.

Cognitive & Memory Pathway Research

Preclinical and clinical studies investigate Selank's influence on learning, memory consolidation pathways, and cognitive signaling research, related to its effects on enkephalin catabolism and neurotransmitter systems.

Registered pharmaceutical in Russia; investigational in most other regions. Stress-response pathway research compound.

Research References